Both PD [39] and AD [40] are characterized by reductions in brain levels of the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a major regulator of mitochondrial number and function, also known to control cellular lipid metabolism, glucose metabolism, electron transport, and certain anti-inflammatory effects. This evidence concerns the gene PPARGC1A and Parkinson disease.